Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Late cornified envelope protein 3D (LCE3D) is a structural protein contributing to the formation of the cornified envelope in the stratum corneum during terminal differentiation of keratinocytes in the epidermis. It is encoded by the LCE3D gene, part of a gene cluster on chromosome 1, and is mainly expressed in skin and certain other epithelial tissues. LCE3D plays a critical role in skin barrier function and keratinization; its dysregulation or deletion has been associated with skin diseases such as psoriasis. The protein acts as a precursor incorporated into the cornified envelope, providing structural integrity to differentiated epithelial cells. Note: LCE3D is not a classic therapeutic target such as a receptor, enzyme, transporter, or transcription factor. It is studied primarily as a marker of keratinocyte differentiation and barrier function, with relevance as a gene associated with susceptibility to certain dermatological diseases rather than as a direct pharmacological target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Late cornified envelope protein 3D (LCE3D).